FARIN AMERSI, M.D.
Radiology at Beverly Blvd, Los Angeles, CA
License number
California A66822
Category
Radiology
Type
Surgical Oncology
Address
Address
8700 Beverly Blvd, Los Angeles, CA 90048
Phone
(310) 423-5470
(310) 659-3928 (Fax)
(951) 303-3391
(951) 346-3627 (Fax)
(310) 659-3928 (Fax)
(951) 303-3391
(951) 346-3627 (Fax)
Personal information
See more information about FARIN AMERSI at radaris.comName
Address
Phone
13173 Pacific Promenade APT 23, Playa Vista, CA 90094
11645 Montana Ave, Brentwood, CA 94513
225 Montana Ave, Santa Monica, CA 90403
Organization information
See more information about FARIN AMERSI at bizstanding.comFarin Amersi MD
8700 Beverly Blvd, Los Angeles, CA 90048
Industry:
Surgeons
Site:
Phone:
(310) 423-0267 (Phone)
Description:
There are 29 doctors at this site. Surgery is not performed at this site.
Farin Fatehali Amersi
FARIN AMERSI MD., A MEDICAL CORPORATION
13173 Pacific Promenade #237, Los Angeles, CA 90094
Status:
Inactive
Registration:
Jul 10, 2006
State ID:
C2898884
Agent:
Farin F Amersi,Los Angeles, CA 90094 (Physical)
Professional information
See more information about FARIN AMERSI at trustoria.com
Use Of Ccr9, Ccl25/Teck, And Nitegrin Alpha4 In Diagnosis And Treatment Of Melanoma Metastasis In The Small Intestine
Use Of Ccr9, Ccl25/Teck, And Nitegrin Alpha4 In Diagnosis And Treatment Of Melanoma Metastasis In The Small Intestine
US Patent:
2009002, Jan 29, 2009
Filed:
Jul 27, 2007
Appl. No.:
11/829507
Inventors:
Dave S.B. Hoon - Los Angeles CA, US
Farin Amersi - Los Angeles CA, US
Farin Amersi - Los Angeles CA, US
Assignee:
John Wayne Cancer Institute - Santa Monica CA
International Classification:
A61K 39/395, C12Q 1/02, C12Q 1/68, G01N 33/53, A61P 31/00, A61K 38/00, A61K 31/7088
US Classification:
4241411, 435 29, 435 6, 435 71, 514 12, 514 44, 4241721
Abstract:
The invention relates to methods for determining whether a melanoma will metastasize or has metastasized to the small intestine in a subject by detecting or quantifying the expression of the CCR9, CCL25/TECK, or integrin α4 gene. Also disclosed are methods for treating subjects so identified.
Use Of Ccr9, Ccl25/Teck, And Integrin Alpha4 In Diagnosis And Treatment Of Melanoma Metastasis In The Small Intestine
Use Of Ccr9, Ccl25/Teck, And Integrin Alpha4 In Diagnosis And Treatment Of Melanoma Metastasis In The Small Intestine
US Patent:
2012030, Nov 29, 2012
Filed:
Aug 2, 2012
Appl. No.:
13/565761
Inventors:
Dave S.B. Hoon - Los Angeles CA, US
Farin Amersi - Los Angeles CA, US
Farin Amersi - Los Angeles CA, US
International Classification:
A61K 31/713, G01N 33/566, G01N 33/574, A61K 39/395, A61P 35/04
US Classification:
4241431, 514 44 A, 4241741, 4241451, 435 612, 436501, 435 723, 435 71, 435 611
Abstract:
The invention relates to methods for determining whether a melanoma will metastasize or has metastasized to the small intestine in a subject by detecting or quantifying the expression of the CCR9, CCL25/TECK, or integrin α4 gene. Also disclosed are methods for treating subjects so identified.
Use Of Ccr9, Ccl25/Teck, And Integrin Alpha4 In Diagnosis And Treatment Of Melanoma Metastasis In The Small Intestine
Use Of Ccr9, Ccl25/Teck, And Integrin Alpha4 In Diagnosis And Treatment Of Melanoma Metastasis In The Small Intestine
US Patent:
2011017, Jul 14, 2011
Filed:
Dec 30, 2010
Appl. No.:
12/982375
Inventors:
Dave S. B. Hoon - Los Angeles CA, US
Farin Amersi - Los Angeles CA, US
Farin Amersi - Los Angeles CA, US
International Classification:
C12Q 1/68, G01N 33/574
US Classification:
435 617, 436501
Abstract:
The invention relates to methods for determining whether a melanoma will metastasize or has metastasized to the small intestine in a subject by detecting or quantifying the expression of the CCR9, CCL25/TECK, or integrin α4 gene. Also disclosed are methods for treating subjects so identified.
Use Of Ccr9, Ccl25/Teck, And Integrin Alpha4 In Diagnosis And Treatment Of Melanoma Metastasis In The Small Intestine
Use Of Ccr9, Ccl25/Teck, And Integrin Alpha4 In Diagnosis And Treatment Of Melanoma Metastasis In The Small Intestine
US Patent:
2011017, Jul 14, 2011
Filed:
Dec 30, 2010
Appl. No.:
12/982670
Inventors:
Dave S. B. Hoon - Los Angeles CA, US
Farin Amersi - Los Angeles CA, US
Farin Amersi - Los Angeles CA, US
International Classification:
A61K 39/395, A61P 35/04, A61K 31/713
US Classification:
4241721, 514 44 A
Abstract:
The invention relates to methods for determining whether a melanoma will metastasize or has metastasized to the small intestine in a subject by detecting or quantifying the expression of the CCR9, CCL25/TECK, or integrin α4 gene. Also disclosed are methods for treating subjects so identified.
Farin Fatehali Amersi, West Hollywood CA
Farin Fatehali Amersi, West Hollywood CA
Specialties:
Surgeon
Address:
8700 Beverly Blvd, West Hollywood, CA 90048
Education:
Doctor of Medicine
Board certifications:
American Board of Surgery Certification in Surgery